Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

Active, not recruitingOBSERVATIONAL

Enrollment

800

Participants

Timeline

Start Date

March 2, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions

Disease Free SurvivalOverall SurvivalPancreatic Cancer

Interventions

BEHAVIORAL

use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins

enrolled patients will be asked details regarding their daily drug use, before and after diagnosis of pancreatic cancer

Trial Locations (1)

IRCCS San Raffaele, Milan

All Listed Sponsors

lead

Massimo Falconi

OTHER